Hemopericardium

Article written and reviewed by Dr Luca Moretti

Hemopericardium is the presence of blood in the pericardial cavity. It may result from cardiac or vascular injury, a procedure, trauma, or bleeding from a diseased pericardium, sometimes promoted by anticoagulation. The contents may remain fluid, form clots, or organize into localized collections. Clinical significance depends on the source, rate and consequences for filling.

Distinguishing active bleeding from a serosanguineous effusion is essential. Red fluid alone does not prove ongoing rupture, just as the presence of anticoagulants is not sufficient to explain the collection. Malignancy, inflammation and contamination during sampling can alter appearance. Diagnosis must identify the mechanism rather than stop at the color observed in the catheter.

Hemopericardium may cause tamponade with relatively modest volumes when it develops rapidly. In this setting, decompression and source control are linked objectives: simple evacuation may be insufficient if perforation or rupture persists and may require immediate coordination with cardiac surgery, interventional cardiology or trauma surgery.

Traumatic, iatrogenic and spontaneous causes

Penetrating trauma may involve cardiac chambers, coronary arteries or great vessels, with blood confined to the pericardium or also dispersed into the pleural space if the sac is torn. This explains why a severe cardiac injury does not always produce a large pericardial collection. The location of the external wound does not reliably reconstruct the internal trajectory. Assessment follows mechanism, stability and anatomic clues, avoiding reassurance based only on an initially negative echocardiographic finding.

Blunt trauma may cause deceleration injuries, compression or associated fractures. The spectrum ranges from myocardial contusion to rupture and vascular injury, with varying severity. Hemopericardium may be recognized immediately or during subsequent deterioration. The traumatic setting requires assessment for extracardiac hemorrhage, pneumothorax and other causes of shock as well. The presence of a collection should not interrupt the overall evaluation of potentially fatal injuries.

Intracardiac procedures may cause perforation during transseptal access, catheter manipulation, ablation or lead implantation. During coronary procedures, vessel injury may spill blood into the sac; structural interventions have their own specific anatomic mechanisms. Timing of onset guides suspicion, but some perforations become apparent later. Procedural anticoagulation and concomitant medications may amplify bleeding without necessarily being its initial cause.

Cardiac surgery may be followed by diffuse bleeding or a localized source. Clots and compartmentalization make the situation different from a simple serous collection. Low chest-tube output does not exclude accumulation if the drain is obstructed or does not communicate with the involved pocket. Reduced output, worsening perfusion and pressure changes must be interpreted together with postoperative anatomy, maintaining a low threshold for cardiac surgical assessment.

Spontaneous rupture may complicate myocardial infarction, proximal aortic dissection or other structural lesions. A new bloody collection after infarction should not simply be labeled pericarditis before free-wall rupture has been considered. Acute chest pain, syncope and signs of malperfusion may suggest aortic disease. Anatomic confirmation should be obtained as rapidly as the clinical condition permits, because definitive treatment consists of managing the lesion, not merely evacuating the collection.

Bleeding from a diseased pericardium may accompany neoplastic infiltration, infection, uremia and inflammation. Anticoagulants and hemostatic disorders may contribute. Reports involving direct oral anticoagulants describe a rare event and do not allow incidence to be estimated from published episodes. Even in these cases, malignancy, renal impairment, interactions and other predispositions must be sought. The term spontaneous means the absence of obvious trauma, not the absence of an identifiable cause.

Blood, clots and pathophysiology of compression

The rate of accumulation limits adaptation of the sac and may produce a rise in pressure with smaller volumes than those tolerated in chronic collections. Absolute volume therefore does not express severity. A small procedural bleed may become immediately significant if the pericardium is poorly distensible. Conversely, a slowly progressive hemorrhagic effusion may initially be compensated while still requiring definition of its cause and surveillance of its dynamics.

Clotting of the contents alters both local pressure and treatment options. Clots may adhere to surfaces and compress specific chambers without being aspiratable through a thin catheter. Failure to obtain blood during an attempt therefore does not exclude a collection. Echogenicity also changes over time, making organized material potentially confusable with adjacent tissues. Procedure selection must account for the physical state of the blood as well as its amount.

Pericardial pressure reduces diastolic expansion and stroke volume. Tamponade may coexist with hemorrhagic hypovolemia, creating mixed shock in which jugular venous distension and classic signs are less evident. Blood loss should not be quantified solely by the initial hemoglobin, which may not yet reflect severity. Assessment includes perfusion, pressure dynamics, response to initial measures and the presence of other bleeding sites.

Compartmentalization is especially important after surgery or previous episodes. A posterior collection may compress the left atrium or other structures and produce a profile different from circumferential tamponade. The first transthoracic echocardiogram may be incomplete because of dressings, air or difficult windows. When symptoms and imaging are discordant, pathophysiology should guide further evaluation, avoiding the conclusion that compression is excluded merely because right ventricular collapse is absent.

The temporary hemostatic effect of pressure may partially contain a lesion, especially in some cardiac or aortic ruptures. Uncontrolled evacuation may remove this balance and increase bleeding. This principle does not justify leaving a patient in collapse untreated; rather, it requires coordination of decompression and repair, deciding when a temporary maneuver is necessary to allow survival until definitive intervention.

Subsequent organization of blood may promote adhesions, an inflammatory response and sometimes constrictive restriction. A residual hematoma may persist or slowly alter filling, requiring anatomic and functional follow-up. Not all adhesions cause clinical disease and not every organized collection requires immediate resection. The decision follows compression, symptoms, evolution and intervention risk, distinguishing a stable sequela from a complication that continues to limit circulation.

Clinical recognition and suspicion in different settings

Sudden collapse during a procedure or after trauma requires rapid consideration of hemopericardium and tamponade. Hypotension, tachycardia, altered mental status and reduced perfusion may precede classic findings. In sedated patients, diagnosis depends on monitoring and imaging because pain and dyspnea cannot be reported. The team must relate the hemodynamic change to the timing of manipulation and activate diagnosis and treatment simultaneously without waiting for a major fall in hemoglobin.

Delayed presentation may include dyspnea, pain, fatigue, syncope or congestion after discharge. The interval from a procedure does not exclude perforation, especially with pacing leads or initially contained lesions. The type of intervention, follow-up, medication changes and last normal examination should be reconstructed. A patient who had recovered and then worsens requires a new assessment without automatically attributing symptoms to post-cardiac injury inflammation.

The antithrombotic history includes the agent, dose, last intake, renal function, interactions and concomitant antiplatelet therapy. Excessive dosing or accumulation may increase risk, but a formally correct regimen does not exclude bleeding. Thrombocytopenia and coagulopathies must also be assessed. The mere presence of an anticoagulant does not prove causality and does not eliminate the need to identify a procedural lesion, tumor or pericardial disease that made hemorrhage possible.

Aortic suspicion increases with acute chest or back pain, syncope, pulse asymmetry, neurologic deficits or new aortic regurgitation. These features may be incomplete. A bloody effusion in this context immediately changes the pathway because surgical repair is the reference treatment. After myocardial infarction, deterioration with a new collection should also prompt consideration of rupture or pseudoaneurysm. A diagnosis of pericarditis should not be used to explain a picture incompatible with simple inflammation.

The physical examination assesses perfusion, blood pressure, jugular veins, pulsus paradoxus, the chest and traumatic signs. Absence of venous distension may reflect hypovolemia, while muffled heart sounds and tachycardia are nonspecific. In trauma, associated injuries may dominate the presentation. An integrated assessment of causes of shock must be maintained, recognizing that tamponade, extracardiac bleeding and respiratory failure may require parallel interventions rather than a single diagnosis.

Slowly hemorrhagic forms may present without apparent urgency, often in the setting of malignancy or other disease. Fluid may be discovered on imaging or drained for dyspnea. Here too, distinguishing active bleeding from a serosanguineous collection matters: not every red sample requires surgical exploration, but every finding should be interpreted in relation to cytology, coagulation, dynamics and possible lesions. Macroscopic appearance is the beginning of reasoning, not its conclusion.

Echocardiographic and CT diagnosis and analysis of pericardial blood

Bedside ultrasound rapidly identifies pericardial contents and consequences for filling. In trauma, focused examination contributes to urgent decision-making, but sensitivity may be limited by air, obesity, wounds and decompression of blood into the pleural space. A negative result does not exclude every cardiac injury when suspicion is high. Clots and regional collections may be inconspicuous and require integration with other windows or modalities compatible with the patient's stability.

Comprehensive echocardiography describes echogenic material, distribution, chamber collapse and ventricular function, while also assessing associated lesions. Postoperatively, transesophageal echocardiography may visualize posterior pockets and compression not recognized transthoracically. The report should clarify limitations and hemodynamic concordance. Absence of a large anechoic effusion does not exclude tamponade from hematoma, while complex contents do not by themselves prove that bleeding is still active.

Contrast-enhanced CT is useful in a patient stable enough to characterize the aorta, thoracic injuries, device position and distribution of the collection. Recent blood may have higher attenuation than simple fluid, but values overlap in the presence of protein, contrast or other conditions. Extravasation points toward an active source, whereas its absence does not exclude intermittent or contained bleeding. The study should answer a question and not delay surgery in instability.

Blood tests include serial complete blood counts, platelets, coagulation, fibrinogen, renal function and perfusion assessment. Blood type and crossmatching are arranged when hemorrhagic risk requires it. A normal prothrombin time or aPTT does not uniformly exclude the effect of all direct anticoagulants; specific tests, when available and timely, may help. A life-saving decision should not depend on waiting for a level that would not return in useful time.

The pericardial sample may be compared with peripheral blood to understand its blood content, but there is no single threshold that identifies all clinical forms and their cause. Coagulation, dilution and duration alter the finding. Distinguishing it from accidental chamber puncture requires imaging and position verification, not merely observation of color or clotting ability. Procedural uncertainty should prompt immediate confirmation before further maneuvers.

Subsequent etiologic investigation includes cytology and microbiologic analysis when the collection is not explained by a definite lesion. Blood does not equal malignancy, and a negative sample does not exclude every infiltration. Targeted biopsy may be useful if suspicious nodules or thickening are present, especially during a procedure that is already indicated. Cardiac MRI has a role in stable patients for characterization of material and tissues but is not a priority examination during hemorrhage with compromise.

Stabilization, hemostasis and management of antithrombotic therapy

Initial stabilization proceeds in parallel with identification and control of the source. Monitoring, access, preparation of blood products and activation of the appropriate team depend on severity and context. When both tamponade and blood loss are present, treatment must address both components. Indiscriminate crystalloid expansion does not correct the restriction or restore hemostasis and may increase dilution and complications, whereas perfusion-guided resuscitation supports transition to definitive therapy.

Temporary interruption of drugs that promote bleeding is considered in clinically relevant hemorrhage, together with reversal when indicated. The decision cannot be separated from thrombotic risk, but control of hemorrhage takes precedence during the life-saving phase. Resumption is planned after stabilization and treatment of the cause, considering prosthetic devices, thromboembolism, atrial fibrillation or recent coronary intervention. No single number of days applies to every hemopericardium.

Specific reversal depends on the drug, time since the last dose, and regulatory and local availability. Unfractionated heparin can be antagonized with protamine; for vitamin K antagonists, major bleeding is managed rapidly with prothrombin complex concentrate and intravenous vitamin K according to protocol. Idarucizumab is the specific antidote for dabigatran in approved indications. For factor Xa inhibitors, authorized antidotes and concentrate-based strategies are selected according to context and updated protocols, without assuming identical availability in every country.

Hemostatic correction also includes platelets, fibrinogen and hemorrhage-related coagulopathy according to results and local protocols. After ablation, heparin reversal may promote cessation of bleeding but requires attention to catheter patency and clot formation. Treatment is not a simple sum of antidotes: drainage, perfusion and anatomy must be monitored. If the source continues to bleed, pharmacologic correction alone does not replace repair.

Respiratory management requires caution because sedation and positive pressure may worsen venous return in tamponade. When intubation is necessary, it should be coordinated with availability of decompression and hemodynamic support. Hypoxemia or associated injuries may make airway control unavoidable, but the specific risk must be anticipated. Temporary improvement with vasopressors should not delay treatment of blood that continues to compress the heart.

Anti-inflammatory drugs are not the initial treatment for active bleeding. A secondary inflammatory response may develop and require later management, but aspirin or NSAIDs may be inappropriate during ongoing hemorrhage. Anticoagulation likewise should not simply be continued or resumed because the collection was drained once. Source stability, residual output and follow-up imaging are needed to build a safe and proportionate plan.

Drainage, repair and choice of therapeutic route

Guided pericardiocentesis may be effective when the blood is fluid and accessible, especially in some iatrogenic tamponades. The catheter allows output to be monitored and rapid reaccumulation to be recognized. Aspiration should be performed with position verification and the ability to manage complications. A favorable response does not prove that the perforation is definitively closed: persistent drainage, renewed instability or a new collection require reassessment and possible transition to surgery.

Surgical evacuation is necessary when clots, loculations or lesions prevent adequate percutaneous treatment. It allows organized material to be removed and the source controlled, with the approach determined by anatomy and context. Postoperatively, timely re-exploration may be the appropriate treatment even if echocardiography does not show a large free space. The decision follows a low-output state and suspicion of compression or bleeding, not merely the visible volume.

Aortic injury requires urgent repair. Uncontrolled drainage before surgery may increase bleeding; in extreme conditions without immediate access to surgery, limited monitored decompression may be used as a bridge to restore sufficient perfusion. This strategy is exceptional and depends on experience and coordination with the receiving center. It should not be interpreted as definitive treatment or authorization to preemptively empty every collection in a dissection.

Myocardial rupture after infarction poses a similar problem of anatomic control. Blood may be temporarily contained by the pericardium and clots, but the balance is unstable. Management requires cardiac surgical involvement and tailored support, with decompression weighed against the need to reach repair. Failure to clearly visualize a defect on the first examination does not exclude the lesion. A strongly suggestive clinical picture should retain priority even when imaging is not definitive.

Cardiac trauma is managed according to mechanism and circulatory status, with emergency surgical procedures when indicated. Pericardiocentesis may serve as a bridge in selected circumstances, but clotted blood and active lesions limit its role. Access to a trauma center and time to surgical control are critical. A pericardial window may have diagnostic or therapeutic value in an appropriate patient, but does not replace repair when a significant lesion is identified.

Non-active hemorrhagic collections due to malignancy or other diseases may follow a different pathway, with drainage for symptoms or compression, fluid analysis and etiologic treatment. A window may reduce selected recurrences. The choice should not be driven solely by the red color of the material. A slowly hemorrhagic effusion must be distinguished from continuous hemorrhage because urgency, objective and procedural risk differ substantially between these scenarios.

Complications, prognosis and surveillance after control

Immediate prognosis depends on time to recognition, ability to decompress and control of the lesion. Prolonged shock and cardiac arrest may leave neurologic and multiorgan damage even after anatomic correction. An iatrogenic event identified and treated promptly may instead resolve without major sequelae. These differences make a single mortality percentage for hemopericardium of little value: traumatic, aortic, postoperative and oncologic populations have distinct risks and mechanisms.

Rebleeding should be sought through the clinical course, catheter output and imaging, also considering obstruction. A drain that suddenly stops working is not always a sign of healing. Catheter removal and resumption of antithrombotic therapy are decided after stability is confirmed, with particular attention to lesions not directly repaired. New deterioration should be considered potentially mechanical until clarified, rather than automatically attributed to pain or convalescence.

Procedural complications include new injuries, arrhythmias, infection and pleuropulmonary problems. Decompression of a major collection may be followed by ventricular dysfunction or pulmonary edema; in this case, bleeding and anatomic complications must first be excluded. Surveillance does not end with the first improvement in blood pressure. Renal function, lactate, urine output and recovery of perfusion help define whether circulation is truly stabilizing.

Post-injury inflammation may appear later with pain, fever and collections. It must be distinguished from residual bleeding, infection and persistent injury before anti-inflammatory therapy is started. Adhesions and organization may also produce late restriction, requiring functional assessment if congestion and reduced exercise tolerance develop. A stable residual hematoma does not automatically mean constriction, but its evolution should be documented in the clinical context.

Prevention of recurrence includes correction of drug interactions, dose review in relation to renal function, and treatment of the underlying pericardial disease. In patients with pacing leads or after specific interventions, follow-up must also verify the anatomic source. The decision regarding antithrombotic therapy requires a written plan balancing hemorrhagic and thrombotic risk, avoiding both unjustified indefinite interruption and automatic resumption without confirmation of stability.

Follow-up should report the established or probable cause, procedure, diagnostic results and residual findings. New dyspnea, syncope, sudden fatigue, progressive pain or reduced urine output require timely reassessment. Return to activity depends on the treated lesion, cardiac function and complications, not merely disappearance of blood on echocardiography. Clear continuity among the interventional center, cardiologist and treating physician helps recognize new accumulation early and maintain necessary therapies safely.

References
1. Schulz-Menger J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041.
2. Klein AL et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988.
3. Adler Y et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921-2964.
4. Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings (Baylor University Medical Center). 2005;18(1):38-55.
5. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine. 2003;349(7):684-690.
6. Ristić AD et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2014;35(34):2279-2284.
7. Madhivathanan PR, Corredor C, Smith A. Perioperative implications of pericardial effusions and cardiac tamponade. BJA Education. 2020;20(7):226-234.
8. Coccolini F et al. Thoracic trauma WSES-AAST guidelines. World Journal of Emergency Surgery. 2025;20:78.
9. Isselbacher EM et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334-e482.
10. Tomaselli GF et al. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2020;76(5):594-622.
11. Tzeis S et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26(4):euae043.
12. Sheikh AB et al. Hemopericardium in the Setting of Direct Oral Anticoagulant Use: An Updated Systematic Review. Cardiovascular Revascularization Medicine. 2022;39:73-83.
13. Mori S et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardio-Oncology. 2024;10:8.
14. Saab J et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathology. 2017;125(2):128-137.
15. Sarode K et al. Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial Entity. International Journal of Angiology. 2024;33(3):139-147.
16. Sagristà-Sauleda J et al. Effusive-constrictive pericarditis. New England Journal of Medicine. 2004;350(5):469-475.